Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-16

Clinical Trial Update: Understanding the Role of Gut Microbiota in Hyperphagia in Prader-Willi Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating the role of gut microbiota in hyperphagia associated with Prader-Willi syndrome; results were posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Prader-Willi Syndrome, Obesity | Phase 2 | Status: COMPLETED | Results posted: 2024-07-16